Davide Fissi, PhD
Eli Lilly Italia SpA
Sr. Principal Engineer Utilities
Davide Fissi is a Senior Principal Engineer at Eli Lilly and Company, with extensive experience in the design, governance, and strategic evolution of Engineering systems supporting pharmaceutical manufacturing.
He joined Eli Lilly in 2014 as a Process Engineer, focusing on HVAC systems. Over time, his role expanded from site-level engineering execution to regional and network technical leadership, with strong emphasis on GMP compliance, system reliability, energy efficiency, AI-tools and risk-based engineering methodologies.
Throughout his career, Davide has acted as Technical Leader for a wide range of systems. He has supported major capital projects and expansion programs across multiple sites, providing technical governance, design review, safety and risk management, and lifecycle engineering oversight. His technical contributions and leadership have been recognized through several Lilly engineering awards.
He is currently involved in the strategic development of advanced technology solutions and AI-tools, contributing to long-term roadmaps focused on capacity, resilience, sustainability of pharmaceutical facilities.
He joined Eli Lilly in 2014 as a Process Engineer, focusing on HVAC systems. Over time, his role expanded from site-level engineering execution to regional and network technical leadership, with strong emphasis on GMP compliance, system reliability, energy efficiency, AI-tools and risk-based engineering methodologies.
Throughout his career, Davide has acted as Technical Leader for a wide range of systems. He has supported major capital projects and expansion programs across multiple sites, providing technical governance, design review, safety and risk management, and lifecycle engineering oversight. His technical contributions and leadership have been recognized through several Lilly engineering awards.
He is currently involved in the strategic development of advanced technology solutions and AI-tools, contributing to long-term roadmaps focused on capacity, resilience, sustainability of pharmaceutical facilities.